Linezolid for drug-susceptible tuberculosis

Lancet Infect Dis. 2019 May;19(5):468-469. doi: 10.1016/S1473-3099(19)30158-6.

Authors

Jiyeon Han¹, Jae-Joon Yim²

Affiliations

¹ Medical Research Collaborating Center, Seoul National University Hospital, Seoul, South Korea.
² Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, South Korea. Electronic address: yimjj@snu.ac.kr.

PMID: 31034390
DOI: 10.1016/S1473-3099(19)30158-6

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents
Humans
Linezolid
Tuberculosis*

Substances

Antitubercular Agents
Linezolid